These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Ganciclovir for CMV retinitis in AIDS. Am Fam Physician; 1989 Feb; 39(2):364. PubMed ID: 2537000 [No Abstract] [Full Text] [Related]
47. Cytomegalovirus retinitis treated with ganciclovir in a renal transplant recipient. Horng IH; Chen MS; Lee PH; Chen YC; Lee CS; Hou PK Taiwan Yi Xue Hui Za Zhi; 1989; 88(11-12):1152-5. PubMed ID: 2561486 [TBL] [Abstract][Full Text] [Related]
48. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation. Stein DS; Verano AS; Levandowski RA Am J Gastroenterol; 1988 Jun; 83(6):684-6. PubMed ID: 2837082 [TBL] [Abstract][Full Text] [Related]
49. Active cytomegalovirus particles in the eyes of an AIDS patient being treated with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (Ganciclovir). Teich SA; Castle J; Friedman AH; Siroty W; Orellana J; Schmitterer M Br J Ophthalmol; 1988 Apr; 72(4):293-8. PubMed ID: 2837272 [TBL] [Abstract][Full Text] [Related]
50. Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Heinemann MH Am J Med; 1992 Feb; 92(2A):12S-16S. PubMed ID: 1310570 [TBL] [Abstract][Full Text] [Related]
51. Patterns of cytomegalovirus retinitis in immunocompromised patients treated with 9-(2-hydroxy-1-(hydroxymethyl)ethoxymethyl) guanine (ganciclovir). D'Antonio D; Iacone A; Fioritoni G; Dell'Isola M; Mastropasqua L; Lobefalo L; De Nicola GC; Paolone V; Di Gregorio P; Recchia A J Chemother; 1991 Jun; 3(3):162-6. PubMed ID: 1655992 [TBL] [Abstract][Full Text] [Related]
54. Effective treatment of cytomegalovirus retinitis and neuritis with retrobulbar ganciclovir after treosulfan-based autologous bone marrow transplant. Raciborska A; Ussowicz M; Prost M; Bilska K; Rodriguez-Galindo C; Rychlowska-Pruszynska M Klin Oczna; 2015; 117(2):101-3. PubMed ID: 26638547 [TBL] [Abstract][Full Text] [Related]
55. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome. Bach MC; Bagwell SP; Knapp NP; Davis KM; Hedstrom PS Ann Intern Med; 1985 Sep; 103(3):381-2. PubMed ID: 2992335 [No Abstract] [Full Text] [Related]
56. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. Erice A; Chou S; Biron KK; Stanat SC; Balfour HH; Jordan MC N Engl J Med; 1989 Feb; 320(5):289-93. PubMed ID: 2536135 [No Abstract] [Full Text] [Related]
57. Treatment of cytomegalovirus retinitis in a patient with AIDS with 9-(1,3-dihydroxy-2-propoxymethyl)guanine. Macdonald EA Can J Ophthalmol; 1987 Feb; 22(1):48-52. PubMed ID: 3028588 [TBL] [Abstract][Full Text] [Related]
58. Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet. Jacobson MA Am J Med; 1992 Feb; 92(2A):26S-29S. PubMed ID: 1310573 [TBL] [Abstract][Full Text] [Related]
59. Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Teich SA; Orellana J; Friedman AH Am J Ophthalmol; 1987 Sep; 104(3):312-4. PubMed ID: 2820231 [No Abstract] [Full Text] [Related]
60. Treatment and prophylaxis of cytomegalovirus disease. Levinson ML; Jacobson PA Pharmacotherapy; 1992; 12(4):300-18. PubMed ID: 1325636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]